ArticleCurrent treatment options in psychiatry2023
Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities.
Article in Current treatment options in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Smartphone Apps and Digital Tools for Managing Schizophrenia and Psychotic Disorders: A Clinical Review.Focus (American Psychiatric Publishing) · 2025Review
- Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- Designing smartphone-based cognitive assessments for schizophrenia: Perspectives from a multisite study.Schizophrenia research. Cognition · 2025Article
- AI-Y: An AI Checklist for Population Ethics Across the Global Context.Current epidemiology reports · 2025Review
- Potential Increasing Trend in Schizophrenia Relapse Prevention in the Past 40 Years: A Bibliometric Analysis.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Review
- Article
- Validity of a smartphone application for self-monitoring psychiatric symptoms in patients with schizophrenia.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Purpose of Review: Schizophrenia presents a significant mental health challenge requiring innovative solutions for relapse prevention, self-management, and health promotion. Patients face an excess mortality gap, driven by increased rates of chronic health conditions, exacerbated in low-resource settings. Digital interventions are a promising avenue to address the multifaceted needs of individuals with schizophrenia. This narrative review synthesizes evidence from digital intervention trials for schizophrenia published from January 2020 to June 2023. Recent Findings: 23 studies were identified, encompassing smartphone applications and web-based platforms to mitigate symptom severity, prevent relapse, and promote physical health. Key developments thus far have shown reduced symptom burden, and enhanced medication adherence and physical activity engagement. Despite more than a decade of research on digital interventions, many trials in this review continued to focus on acceptability and feasibility, with emphasis on patient uptake. This suggests the field has shown limited advancement in effectiveness studies of digital interventions. Summary: As the field evolves, further fully powered effectiveness studies, greater emphasis on implementation studies for digital tools for schizophrenia, and attention on digital health equity and evidence generation among those in lower-income countries are warranted. These findings hold implications for clinicians, researchers, and policymakers towards optimizing digital care for individuals with schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.